Evidence map›Paper›PMID 33208300›Full record

ArticleJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2021

Defective immunometabolism pathways in cystic fibrosis macrophages.

Kaitlin Hamilton, Kathrin Krause, Asmaa Badr, Kylene Daily, Shady Estfanous, Mostafa Eltobgy, Arwa Abu Khweek, Midhun N K Anne, Cierra Carafice, Daniel Baetzhold and 5 more

Abstract read
In one paragraph

Article in Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. mSphere · 2026
    Article
  2. Article
  3. bioRxiv : the preprint server for biology · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Common methods in mitochondrial research (Review).International journal of molecular medicine · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Kaitlin HamiltonDepartment of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Kathrin KrauseDepartment of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Asmaa BadrDepartment of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Kylene DailyDepartment of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Shady EstfanousDepartment of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Mostafa EltobgyDepartment of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Arwa Abu KhweekDepartment of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210, USA; Department of Biology and Biochemistry, Birzeit University, Birzeit, West Bank, Palestine.
Midhun N K AnneDepartment of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Cierra CaraficeDepartment of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Daniel BaetzholdDepartment of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Jeffrey R TonnigesCampus Microscopy and Imaging Facility, The Ohio State University, Columbus, OH 43210, USA.
Xiaoli ZhangCenter for Biostatistics, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Mikhail A GavrilinDepartment of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Narasimham L ParinandiDepartment of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Amal O AmerDepartment of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210, USA. Electronic address: Amal.Amer@osumc.edu.

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Unraveling the role of the CFTR ion channel in susceptibility to SARS-CoV-2 infection and inflammationR01AI124121 · NIAID · OHIO STATE UNIVERSITY · PI AMER, AMAL O, CORMET-BOYAKA, ESTELLE A · 2016 to 2020
$3.7M
The role of microRNA-calibrated autophagy in innate immunity and inflammationR01HL127651 · NHLBI · OHIO STATE UNIVERSITY · PI AMER, AMAL O, CORMET-BOYAKA, ESTELLE A · 2015 to 2018
$1.5M
Interdisciplinary Program in Microbe-Host BiologyT32AI112542 · NIAID · OHIO STATE UNIVERSITY · PI JUSTICE, SHERYL S, WOZNIAK, DANIEL J · 2014 to 2018
$644k
Alzheimer’s Disease Biomarker for Diagnosis and PrognosisR21AG067755 · NIA · OHIO STATE UNIVERSITY · PI AMER, AMAL O, TARAWNEH, RAWAN · 2020 to 2021
$417k
Mechanistic basis of inflammation in Alzheimers DiseaseR21AG064899 · NIA · OHIO STATE UNIVERSITY · PI AMER, AMAL O · 2020 to 2021
$409k
NCI NIH HHS P30 CA016058NHLBI NIH HHS R01 HL127651NIAID NIH HHS R01 AI124121NIAID NIH HHS T32 AI112542NIA NIH HHS R21 AG064899NIA NIH HHS R21 AG067755
6 · The paper itself

Abstract

backgroundMitochondria play a key role in immune defense pathways, particularly for macrophages. We and others have previously demonstrated that cystic fibrosis (CF) macrophages exhibit weak autophagy activity and exacerbated inflammatory responses. Previous studies have revealed that mitochondria are defective in CF epithelial cells, but to date, the connection between defective mitochondrial function and CF macrophage immune dysregulation has not been fully elucidated. Here, we present a characterization of mitochondrial dysfunction in CF macrophages.

methodsMitochondrial function in wild-type (WT) and CF F508del/F508del murine macrophages was measured using the Seahorse Extracellular Flux analyzer. Mitochondrial morphology was investigated using transmission electron and confocal microscopy. Mitochondrial membrane potential (MMP) as well as mitochondrial reactive oxygen species (mROS) were measured using TMRM and MitoSOX Red fluorescent dyes, respectively. All assays were performed at baseline and following infection by Burkholderia cenocepacia, a multi-drug resistant bacterium that causes detrimental infections in CF patients.

resultsWe have identified impaired oxygen consumption in CF macrophages without and with B. cenocepacia infection. We also observed increased mitochondrial fragmentation in CF macrophages following infection. Lastly, we observed increased MMP and impaired mROS production in CF macrophages following infection with B. cenocepacia.

conclusionsThe mitochondrial defects identified are key components of the macrophage response to infection. Their presence suggests that mitochondrial dysfunction contributes to impaired bacterial killing in CF macrophages. Our current study will enhance our understanding of the pathobiology of CF and lead to the identification of novel mitochondrial therapeutic targets for CF.

Indexed as

AnimalsCystic FibrosisMacrophagesMiceMice, Inbred C57BLMitochondriaBacterial infectionImmunometabolismMacrophageMitochondriaReactive oxygen species

Identifiers

PMID33208300
PMCPMC8121894

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.